FDA approves Eli Lilly’s Olumiant oral tablets for alopecia By: MarketWatch June 13, 2022 at 16:05 PM EDT The U.S. Food and Drug Administration said Monday it approved Eli Lilly & Co.'s Olumiant oral tablets to treat adults with severe alopecia areata. Read More >> Related Stocks: Eli Lilly